Blake borgeson recursion

Author: udvi

August undefined, 2024

WebBlake Borgeson. Co-founder and CTO at Recursion Pharmaceuticals. Location: Austin, Texas. Add to My Lists. Computational biologist and entrepreneur aiming with my career to bring >>1% of the level of computational resources and talent currently devoted to improving Google’s search engine to bear on biology and diseases. WebRecursion Pharmaceuticals, Inc. is a Salt Lake City based biotechnology company. The company was founded in November 2013 by Blake Borgeson, Chris Gibson, and Dean Li. The company uses machine learning to discover and evaluate possible treatments. The company has partnerships with Takeda Pharmaceutical Company, Genzyme, Sanofi, …

Blake Borgeson Sells 8,885 Shares of Recursion Pharmaceuticals, …

WebView Blake Borgeson's email address (b*****@recurs***.com) and phone number. Blake works at Recursion Pharmaceuticals as Co-founder, Board Member. Blake is based out … WebRecursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. ... Blake Borgeson Ph.D: Recursion ... hillsong founder scandal

RXRX Recursion Pharmaceuticals Inc - Ordinary Shares - Class A - Stocktwits

WebApr 9, 2024 · On Tuesday, March 21st, Blake Borgeson sold 8,885 shares of Recursion Pharmaceuticals stock. The stock was sold at an average price of $7.40, for a total value … WebMar 25, 2024 · Blake Borgeson Sells 8,885 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock; Parker-Hannifin Co. (NYSE:PH) Shares Acquired by Ronald … WebBlake Borgeson Recursion Pharmaceuticals Anna Salamon Center For Applied Rationality Nate Soares Machine Intelligence Research Institute Edwin Evans Linc Board leadership practices. SOURCE: Self-reported by organization. hillsong first love lyrics

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Blake Borgeson ...

Recursion Pharmaceuticals Announces Research …

WebOct 4, 2024 · Raytheon Technologies Wins Hypersonic Missile Contract Worth $985M. Posted by Keala Milles on Sep 23rd, 2024 . The United States Air Force (USAF) recently announced the awarding of a contract to ... WebFeb 23, 2024 · Blake Borgeson owns about 7,594,057 units of Recursion Pharmaceuticals, Inc common stock. In the last 2 years at Recursion Pharmaceuticals, Inc, Blake Borgeson has sold an estimated value of $1 ... smart lock simplisafeWebOct 3, 2016 · Recursion Pharmaceuticals today announced its $12.9 million Series A round of funding, led by leading deep technology investor Lux Capital, with parti smart lock purpose

"WebBlake Borgeson is a Board Member and General Advisor at Machine Intelligence Research Institute and the Co-Founder, Board Member of Recursion Pharmaceuticals. He … " - Blake borgeson recursion

Blake borgeson recursion

WebJul 25, 2024 · They were joined by a third co-founder, bioinformatician Blake Borgeson. ... Recursion hopes the data set will spur outside researchers to develop new machine learning techniques. WebApr 8, 2024 · Blake Borgeson Sells 8,885 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock. Posted by Defense World Staff on Apr 8th, 2024

Did you know?

WebBlake Borgeson is Board Member at Recursion Pharmaceuticals Inc. See Blake Borgeson's compensation, career history, education, & memberships. WebOct 25, 2016 · Recursion Pharmaceuticals, an emerging biotech in Salt Lake City, today announced that successful and serial technology entrepreneur and executive John Pereira, MBA, has joined the team as Chief ...

WebFeb 8, 2024 · Led by John Pereira, chief operating officer, Chistopher C. Gibson, PhD, Co-Founder & CEO, Blake Borgeson, PhD, Co-Founder & CTO, Recursion Pharmaceuticals leverages advanced biological science ...

WebBlake Borgeson MIRI + Recursion, AI + biology Berkeley, CA. Blake Borgeson -- United States. Blake Borgeson Intern at Lilly Bunn, Inc. … WebApr 25, 2016 · Blake Borgeson, CTO of Recursion, added, “Rare diseases are the perfect targets for our unbiased, target-agnostic discovery platform as relatively little is known …

WebRecursion Initiates Phase 2 Trial for the Potential Treatment of Familial Adenomatous Polyposis (FAP) and a Phase 1 trial for the Potential Treatment of Clostridium difficile (C. …

WebApr 4, 2024 · RECURSION PHARMACEUTICALS, INC.: Borgeson Blake (Director) Sells 8,885 @ Avg Price: $7.40 (Form4) RECURSION PHARMACEUTICALS, INC.: Gibson Christopher (Director, Chief Executive Officer) (Form4 ... hillsong from the inside out lyricsWebRecursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. ... The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake ... hillsong founder resignsWebBlake Borgeson is Board Member at Recursion Pharmaceuticals Inc. See Blake Borgeson's compensation, career history, education, & memberships. hillsong germany youtubeWebApr 5, 2024 · The estimated net worth of Blake Borgeson is at least $48.64 million as of March 21st, 2024. Dr. Borgeson owns 7,576,287 shares of Recursion Pharmaceuticals … hillsong funeralWebJan 27, 2024 · Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 8,885 shares of the stock in a transaction on Tuesday, January … smart lock schlossWebJan 19, 2024 · Include Sam Altman (OpenAI), Jaan Tallinn (Skype), Blake Borgeson (Recursion Pharmaceuticals) Gameto (New York) 2024. $40 million. Include Future Ventures, Anne Wojcicki (23andMe), Bold Capital Partners, Lux Capital, Plum Alley, TA Ventures, Overwater Ventures, ARCH Venture Partners. Dioseve (Tokyo) 2024. JPY 400 … hillsong full song youtubeWebRecursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and … hillsong global project